UnitedHealth Group Inc (UNH) : Mark Sheptoff Financial Planning reduced its stake in UnitedHealth Group Inc by 3.59% during the most recent quarter end. The investment management company now holds a total of 34,782 shares of UnitedHealth Group Inc which is valued at $4,486,878 after selling 1,297 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on May 9, 2016.UnitedHealth Group Inc makes up approximately 3.65% of Mark Sheptoff Financial Planning’s portfolio.
Other Hedge Funds, Including , Advantus Capital Management Inc boosted its stake in UNH in the latest quarter, The investment management firm added 583 additional shares and now holds a total of 92,552 shares of UnitedHealth Group Inc which is valued at $11,939,208. UnitedHealth Group Inc makes up approx 0.36% of Advantus Capital Management Inc’s portfolio.Bronfman E.l. Rothschild boosted its stake in UNH in the latest quarter, The investment management firm added 951 additional shares and now holds a total of 8,546 shares of UnitedHealth Group Inc which is valued at $1,128,414. UnitedHealth Group Inc makes up approx 0.20% of Bronfman E.l. Rothschild’s portfolio. Kalos Management sold out all of its stake in UNH during the most recent quarter. The investment firm sold 1,799 shares of UNH which is valued $237,540.Hudson Canyon Investment Counselors reduced its stake in UNH by selling 623 shares or 5.45% in the most recent quarter. The Hedge Fund company now holds 10,807 shares of UNH which is valued at $1,426,956. UnitedHealth Group Inc makes up approx 1.64% of Hudson Canyon Investment Counselors’s portfolio.Bedrijfstakpensioenfonds Voor De Media Pno reduced its stake in UNH by selling 3,300 shares or 25.0% in the most recent quarter. The Hedge Fund company now holds 9,900 shares of UNH which is valued at $1,303,632. UnitedHealth Group Inc makes up approx 0.19% of Bedrijfstakpensioenfonds Voor De Media Pno’s portfolio.
UnitedHealth Group Inc closed down -0.74 points or -0.57% at $129 with 31,37,335 shares getting traded on Friday. Post opening the session at $129.1, the shares hit an intraday low of $128.55 and an intraday high of $130.03 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, UnitedHealth Group Inc reported $1.81 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.72. The company had revenue of $44527.00 million for the quarter, compared to analysts expectations of $44278.96 million. The company’s revenue was up 24.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.
Many Wall Street Analysts have commented on UnitedHealth Group Inc. Company shares were Reiterated by Mizuho on Apr 20, 2016 to “Buy”, Firm has raised the Price Target to $ 156 from a previous price target of $150 .Company shares were Reiterated by FBR Capital on Apr 19, 2016 to “Outperform”, Firm has raised the Price Target to $ 145 from a previous price target of $130 .Company shares were Reiterated by Mizuho on Mar 15, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $131 .
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.